PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET

7.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA PHARMACEUTICALS AND BIOTECHNOLOGY R AND D MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 ROCHE

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 JOHNSON And JOHNSON

16.3 MERCK

16.4 NOVARTIS

16.5 PFIZER

16.6 SANOFI

16.7 BAYER

16.8 BRISTOL-MYERS SQUIBB

16.9 ASTRAZENECA

16.10 GLAXOSMITHKLINE

16.11 ABBVIE

16.12 ELI LILLY

16.13 BOEHRINGER SOHN

16.14 AMGEN

16.15 GILEAD SCIENCES

16.16 TAKEDA PHARMACEUTICAL

16.17 NOVO NORDISK

16.18 BIOGEN

16.19 ABBOTT

16.20 ASTELLAS PHARMA

16.21 TEVA PHARMACEUTICAL INDUSTRIES

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER